ACTAMONE

Active ingredients

The drug ACTAMONE contains one active pharmaceutical ingredient (API):

UNII U1O3J18SFL - MONTELUKAST SODIUM

Montelukast is an orally active compound which binds with high affinity and selectivity to the CysLT1 receptor. Τhe CysLT type-1 (CysLT1) receptor is found in the human airway (including airway smooth muscle cells and airway macrophages) and on other pro-inflammatory cells (including eosinophils and certain myeloid stem cells). CysLTs have been correlated with the pathophysiology of asthma and allergic rhinitis.

Read about Montelukast

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
R03DC03
Montelukast
R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DC Leukotriene receptor antagonists
Discover more medicines within R03DC03

Authorization and marketing

This brand name is authorized in the following countries: Singapore

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
SG
Health Sciences Authority
Identifier(s): 15015P, 15016P, 15017P